Apologies for the redundancy above. People should keep in mind that if MSB has to do another trial for Covid we will almost certainly go back to the Mt Sinai type stats which will result in an early termination to the trial for over whelming efficacy. It would be smart to design a trial for a smaller % than 43% like last time, only less than 65's etc etc and let the stats that come up well exceed the trial parameters.
Can have a separate trial for over 65's but in any case the stats need to be separated and the treatments different as well.
It will probably be a very easy pass next time out.
NSW COVID FORECAST, page-32
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.81 |
Change
0.000(0.00%) |
Mkt cap ! $3.222B | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1130 | $3.08 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.53 | 10 | 1 |
View Market Depth
| Last trade - 16.17pm 10/01/2025 (20 minute delay) ? |
| MSB (ASX) Chart |
Day chart unavailable
